Overcoming the barriers to HPV vaccination in high-risk populations in the US

Gynecologic Oncology

Volumn 117, Issue 3, 2010, Pages 486-490

  Downs Jr , Levi S ^a   Scarinci, Isabel ^b   Einstein, Mark H ^c   Collins, Yvonne ^d   Flowers, Lisa ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Alabama at Birmingham   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Cancer prevention; Cervical cancer; Health disparities; HPV vaccine

Indexed keywords

WART VIRUS VACCINE;

AWARENESS; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CULTURAL FACTOR; ETHNICITY; HEALTH BELIEF; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; INCOME; MORTALITY; POVERTY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; UNITED STATES; UTERINE CERVIX CANCER;

FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 77951891800     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.02.011     Document Type: Review

References (38)

1. American Cancer Society. Cancer Facts & Figures 2008 (2009), American Cancer Society, Atlanta, Georgia
2. Freeman H., and Wingrove B. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities (2005) NIH Pub. No. 05-5282
3. Smith H.O., Tiffany M.F., Qualls C.R., and Key C.R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol 78 (Aug 2000) 97-105
4. Smith J.S. Ethnic disparities in cervical cancer illness burden and subsequent care: a prospective view in managed care. Am J Manag Care 14 (Jun 2008) S193-S199
5. Kahn J.A., Lan D., and Kahn R.S. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 110 (Jul 2007) 87-95
6. Howe H.L., Wu X., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107 (Oct 15 2006) 1711-1742
7. Singh G.K., Miller B.A., Hankey B.F., and Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 101 (Sep 1 2004) 1051-1057
8. In: Ries L., Melbert D., Krapcho M., Stinchcomb D.G., Howlander N., Horner M.J., et al. (Eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, based on November 2007 SEER data submission, posted to the SEER web site, 2008 (2008). http://seer.cancer.gov/csr/1975_2004/ http://seer.cancer.gov/csr/1975_2004/
9. US Census Bureau. US Population Projections. 2008; http://www.census.gov/population/www/projections/summarytables.html. Accessed January 22, 2009.
10. CDC. DATA 2010. The Healthy People 2010 database. The Centers for Disease Control and Prevention (2007). http://wonder.cdc.gov/scripts/broker.exe http://wonder.cdc.gov/scripts/broker.exe. Accessed May 15, 2007
11. Eggleston K.S., Coker A.L., Das I.P., Cordray S.T., and Luchok K.J. Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt). 16 (Apr 2007) 311-330
12. Centers for Disease Control and Prevention. Health Risk Behaviors by Race/Ethnicity (2007), National YRBS
13. Downs L.S., Smith J.S., Scarinci I., Flowers L., and Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol 109 (May 2008) S22-S30
14. Howell E.A., Chen Y.T., and Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol 94 (Oct 1999) 509-515
15. Brookfield K.F., Cheung M.C., Lucci J., Fleming L.E., and Koniaris L.G. Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer 115 (Jan 1 2009) 166-178
16. Merrill R.M., Merrill A.V., and Mayer L.S. Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethn Dis Spring-Summer 10 (2000) 248-256
17. McCracken M., Olsen M., Chen M.S., Jemal A., Thun M., Cokkinides V., et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese,Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57 (2007) 190-205
18. Bates J.H., Hofer B.M., and Parikh-Patel A. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990-2004. Cancer 113 (Nov 15 2008) 2955-2963
19. Seeff L.C., and McKenna M.T. Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996. Cancer Detect Prev 27 (2003) 203-208
20. Garner E.I. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 12 (Mar 2003) 242s-247s
21. Penchansky R., and Thomas J.W. The concept of access: definition and relationship to consumer satisfaction. Med Care 19 (1981) 127-140
22. Scarinci I.C., Slawson D.L., Watson D.L., Klesges R.C., and Murray D.M. Socioeconomic status, ethnicity, and health care access among young and healthy women. Ethn Dis 11 (2001) 60-71
23. Sambamoorthi U., and McAlpine D.D. Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. Prev Med 37 (Nov 2003) 475-484
24. Behbakht K., Lynch A., Teal S., Degeest K., and Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol 104 (Dec 2004) 1355-1361
25. Ponce N.A., Chawla N., Babey S.H., et al. Is there a language divide in pap test use?. Med Care 44 (Nov 2006) 998-1004
26. Prislin R., Sawyer M.H., Nader P.R., Goerlitz M., De Guire M., and Ho S. Provider-staff discrepancies in reported immunization knowledge and practices. Prev Med 34 (May 2002) 554-561
27. Klug S.J., Hukelmann M., and Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med 46 (Feb 2008) 87-98
28. Tiro J. What do women in the U.S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol Biomarkers Prev 16 (2007) 288-294 288
29. Constatine N., and Jerman P. Acceptance of human papillomarvirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40 (2007) 108-115
30. Watts L.A., Joseph N., Wallace M., et al. HPV vaccine: a comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol 112 (Mar 2009) 577-582
31. Bair R.M., Mays R.M., Sturm L.A., and Zimet G.D. Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol 21 (Dec 2008) 329-334
32. Fazekas K.I., Brewer N.T., and Smith J.S. HPV vaccine acceptability in a rural Southern area. J Womens Health (Larchmt) 17 (May 2008) 539-548
33. Scarinci I.C., Garcés-Palacio I.C., and Partridge E.E. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health (Larchmt) 16 (Oct 2007) 1224-1233
34. Friedman A.L., and Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav. 34 (Jun 2007) 471-485
35. Centers for Medicare and Medicaid. PQTI Overview. 2008; http://www.cms.hhs.gov/pqri/. Accessed February 13, 2009.
36. Goff B.A. Quality measures in gynecologic cancers: what and when?. Gynecol Oncol 110 (Jul 2008) 3-4
37. Haber G., Malow R.M., and Zimet G.D. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol. 20 (Dec 2007) 325-331
38. Breitkopf C.R., Pearson H.C., and Breitkopf D.M. Poor knowledge regarding the Pap test among low-income women undergoing routine screening. Perspect Sex Reprod Health 37 (Jun 2005) 78-84